Faces Behind the Tools: Dávid and Szabolcs, Akceso’s Newest Techie Pillars for IRP and MFN Excellence
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
We are happy to introduce Dávid and Szabolcs, the two newest members of our Techie team, both joined recently in 2025.
Akceso Advisors AG, a leading independent global advisory firm specializing in market access, pricing, reimbursement strategy, operations and policy-setting for life-science companies and authorities, announced today the election of Dr. Seng Chin Mah as a new non‑executive member of its Board of Directors.
Akceso Advisors elects Dr. Seng Chin Mah as Board Member Read More »
One of the things that I have learnt during my time with Akceso is that, if you believe that something is good and brings value, do not wait to start doing it.
One of the things I learnt from Akceso – always welcome challenges Read More »
’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.
Why the World needs Catalysts? Read More »
Working remotely is here to stay! The Covid pandemic gave it an enormous boost. While working remotely has a lot of benefits, it is not all rosy.
We are happy to share with you the blog post of András Incze, CEO of Akceso Advisors on what was accomplished, how we made an impact with our international team in these challenging times and lived up again to our promise.
We Look Back To A Remarkable Year 2021 Read More »
4 good reasons of running marathon: Read thoughts of András Incze about how marathon running became a passionate habit for him and how it reflects in Akceso.
The Essence of 17 Years in Marathon Running Read More »
Károly Dénes has joined our team in February 2021. Meet our newest Akcesoian!
Károly Dénes has joined to Akceso Read More »
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access across the globe. Since its launch in June 2015 we have covered more than 8,000 stories from over 160 countries.